首页 > 市场调查报告书 > 食物/饮料

保健食品

市场调查报告书

商品编码

1455768

全球乳化维生素 D3 市场 - 2023-2030

Global Emulsified Vitamin D3 Market - 2023-2030

出版日期: 2024年03月26日 | 出版商:

DataM Intelligence | 英文 225 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2022年，全球乳化维生素D3市场达到5.8811亿美元，预计2030年将达到8.9574亿美元，2023-2030年预测期间CAGR为5.4%。

现代生活方式往往导致在户外工作、休閒或防晒的时间减少，限制了皮肤中天然维生素 D 的产生，而皮肤是大多数人的主要来源。维生素 D3 是骨骼健康、骨质疏鬆症和佝偻病防治所需的重要维生素。它具有多种作用，用于食品、饲料和医疗保健行业。骨质疏鬆症、自体免疫疾病和某些癌症等慢性疾病的全球盛行率正在上升。

维生素 D 充足与降低某些疾病的风险有关，从而推动了乳化维生素 D3 的市场。乳化维生素D3有多种剂型，如滴剂和咀嚼片，方便不同年龄层和喜好的人食用。人们对维生素 D 缺乏症的认识不断提高、可支配收入增加以及新医疗保健技术的不断采用等因素都有助于全球市场的扩张。

北美主导了全球乳化维生素 D3 市场。根据骨骼健康与骨质疏鬆基金会 2021 年 8 月的数据，大约 1,000 万美国人患有骨质疏鬆症，另外 4,400 万美国人骨密度低，这使他们面临更大的风险。 5,400 万美国人（占 50 岁及以上成年人的一半）面临骨折风险，应该关注骨骼健康。用于治疗各种缺乏症的维生素 D 的高需求正在推动市场成长。

动力学

全球维生素缺乏症日益严重

根据美国国立卫生研究院统计，2023年7月，全球约有10亿人缺乏维生素D，50%的人口维生素D不足。随着人们对维生素D缺乏症的认识不断提高，人们越来越需要补充维生素缺乏症以维持良好的健康状况，因此增加了维生素D3的补充。

根据2017年至2020年3月进行的全国健康与营养调查，约3%的年轻人和18.5%的成年人报告使用维生素D补充剂。在那些报告服用维生素 D 补充剂的人中，33.9% 的年轻人和 66.9% 的成年人连续 30 天每天服用补充剂。应对维生素缺乏症的补充需求越高，由于乳化维生素 D3 的有效性质，对它的需求也越大。

乳化维生素 D3 的好处

乳化维生素D3补充剂提供了一种简单有效的方法来增加维生素D摄取量，不受阳光照射或饮食限制的影响，增加日常生活中的补充习惯。随着人们对维生素 D 缺乏症的认识不断增强，乳化 D3 瞄准了更广泛的年龄范围，从年轻人到关注骨骼健康的老年人。维生素 D 与多种健康益处有关，乳化产品以其更好的吸收性和便利性迎合了人们对预防措施的关注。

乳化过程将维生素 D3 分解成更小的颗粒，与传统的片剂或胶囊相比，可以更好地在肠道中吸收。这对于有消化问题或无法有效吸收营养的人尤其有益。乳化维生素 D3 有多种形式，如滴剂和软糖，使儿童、老年人或吞嚥药片有困难的人更容易食用。

乳化维生素D3成本高

传统的维生素 D3 补充剂的製造相对简单。它们涉及混合干燥成分并将其压製成片剂或胶囊。乳化选项需要额外的步骤。维生素 D3 需要使用特殊的乳化剂分散到液体载体。此製程较为复杂，需专用设备，导致生产成本较高。

乳化配方通常使用油和乳化剂等附加成分来形成稳定的乳液。与传统补充剂中使用的简单成分相比，这些额外成分会增加整体成本。与传统维生素D3相比，乳化维生素D3的生产流程和成分使其成本更高。对价格敏感的客户选择低价产品，阻碍了市场成长。

Modern lifestyles often involve spending less time outdoors for work, leisure or sun protection, limiting natural vitamin D production in the skin, a primary source for most people. Vitamin D3 is an important vitamin needed for bone health osteoporosis and rickets aversion. It has various roles and is used in the food, feed and healthcare industries. The global prevalence of chronic diseases like osteoporosis, autoimmune disorders, and certain cancers is on the rise.

Vitamin D sufficiency is linked to a reduced risk of developing some of the various conditions, propelling the market for emulsified vitamin D3. Emulsified vitamin D3 comes in various forms like liquid drops and chewable tablets, making them easy to consume for different age groups and preferences. Factors like rising awareness of vitamin D deficiency, increasing disposable income, and growing adoption of new healthcare technologies contribute to market expansion globally.

North America dominated the global emulsified vitamin D3 market. According to Bone Health & Osteoporosis Foundation August 2021, approximately 10 million Americans have osteoporosis and another 44 million have low bone density, placing them at increased risk. 54 million Americans, half of all adults age 50 and older, are at risk of breaking a bone and should be concerned about bone health. The high demand for vitamin D to deal with various deficiency disorders is driving market growth.

Dynamics

Increasing Vitamin Deficiency Worldwide

According to the National Institutes of Health, in July 2023, about 1 billion people worldwide had vitamin D deficiency, while 50% of the population had vitamin D insufficiency. With growing awareness of vitamin D deficiency, there is a greater need for supplementation for vitamin deficiency to maintain good health conditions, increasing the supplementation for vitamin D3.

According to the National Health and Nutrition Examination Survey conducted from 2017 to March 2020, around 3% of young people and 18.5% of adults reported using vitamin D supplements. Of those who reported using vitamin D supplements, 33.9% of young people and 66.9% of adults took the supplement every day for 30 days. The higher the need for supplementation to deal with vitamin deficiencies, there is also greater demand for the emulsified vitamin D3 due to its effective nature.

Benefits of Emulsified Vitamin D3

Emulsified vitamin D3 supplements provide a simple and effective way to increase vitamin D intake, regardless of sun exposure or dietary limitations, increasing the supplementation habits in daily life. With growing awareness of vitamin D deficiency, emulsified D3 is targeting a wider age range, from young adults to seniors concerned about bone health. Vitamin D is linked to various health benefits, and emulsified options cater to this focus on preventative measures with their improved absorption and convenience.

The emulsification process breaks down vitamin D3 into smaller particles, allowing for better absorption in the gut compared to traditional tablets or capsules. This is especially beneficial for individuals with digestive issues or those who may not absorb nutrients effectively. Emulsified vitamin D3 comes in various forms like liquid drops and gummies, making it easier to consume for children, elderly individuals, or those who have trouble swallowing pills.

High-Cost of Emulsified Vitamin D3

Traditional vitamin D3 supplements are relatively simple to manufacture. They involve mixing dry ingredients and compressing them into tablets or capsules. Emulsified options require additional steps. The vitamin D3 needs to be dispersed into a liquid carrier using special emulsifying agents. This process is more complex and requires specialised equipment, contributing to higher production costs.

Emulsified formulas often use additional ingredients like oils and emulsifiers to create a stable emulsion. These additional ingredients can add to the overall cost compared to the simpler ingredients used in traditional supplements. The production process and ingredients of the emulsified vitamin D3 make them costlier compared to traditional vitamin D3. Price-sensitive customers choose low-priced products hindering the market growth.

Segment Analysis

The global emulsified vitamin D3 market is segmented based on dosage, form, flavor, target audience, distribution channel, application and region.

High Vitamin D Deficiency Among Adult Population

The global emulsified vitamin D3 market is segmented based on target audience into infants and children, pregnant and lactating women and adults. Each target audience benefits from the emulsified vitamin D3 in a similar manner, but the need and use of vitamin D3 among adults is higher compared to other age groups driving the segment growth. According to the August 2022, American Academy of Pediatrics 32% of young adults were deficient in vitamin D.

In the adult population, 35% of adults in United States are vitamin D deficient whereas over 80% of adults in Pakistan, India, and Bangladesh are vitamin D deficient. Similarly, 61% of the elderly population is vitamin D deficient in United States, whereas 90% in Turkey, 96% in India, 72% in Pakistan, and 67% in Iran were vitamin D deficient. To deal with the increasing deficiencies among the age groups, there is a higher demand for emulsified vitamin D3 for an efficient vitamin supply into the body.

Geographical Penetration

High Prevalence of Vitamin Deficiency in North America

North America dominated the global emulsified vitamin D3 market. Regional countries such as United States and Canada have a high prevalence of vitamin D deficiency. In the United States, 47% of African American infants and 56% of Caucasian infants have vitamin D deficiency. About 50% to 60% of nursing home residents and hospitalized patients have vitamin D deficiency in U.S.

Public health campaigns and media attention have raised awareness of this issue, leading to increased interest in vitamin D supplementation. People in North America are increasingly interested in preventive healthcare and taking a proactive approach to managing their health. The North American market is often receptive to new technologies and products. Emulsified Vitamin D3 is a relatively innovation, and North American companies are quicker to adopt and manufacture it compared to other regions.

Competitive Landscape

The major global players in the market include BASF, Biotics Research Corporation, Adaptogen Research, Body of Harmony, bodykind Ltd., Naka Pro, Nutri-Link, gnanaturals, Nutra Biogenesis and Designs for Health, Inc.

COVID-19 Impact Analysis

The COVID-19 pandemic had both positive and negative impact on the global market. The pandemic caused disruptions in global supply chains for raw materials and manufacturing processes. This led to temporary shortages or price fluctuations for emulsified Vitamin D3 supplements. The economic impact of COVID-19 has led some consumers to cut back on discretionary spending, potentially affecting sales of non-essential items like vitamin supplements.

The pandemic highlighted the importance of a strong immune system. Research studies suggesting a potential link between vitamin D sufficiency and reduced risk of respiratory infections have boosted interest in vitamin D supplementation. This has likely driven demand for emulsified vitamin D3 due to its potentially better absorption. A surge in e-commerce for various products, including health supplements, had a positive impact on the market as well.

By Dosage

Low Dose (400 IU)
Medium Dose (1,000 IU)
High Dose (2,000 IU or more)

By Form

Softgels
Liquids (Drops)
Chewable Tablets

By Flavor

Raspberry
Lemon
Orange
Others

By Target Audience

Infants and Children
Pregnant and Lactating Women
Adults

By Distribution Channel

Pharmacies and Drugstores
Specialty Stores
E-Commerce
Others

By Application

Food
Feed
Healthcare

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Russia
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Key Developments

In February 2024, Cadila Pharmaceuticals, an Indian pharmaceutical company announced the launch of the first-ever aqueous injection of vitamin D.
In February 2022, Amway launched a range of nutrition supplements. Nutrilite D-Fence Vitamin D3 Jelly Strip are in trendy, tasty, convenient and simplified formats.
In February 2021, DSM announced the approval of a new Certificate of Suitability for a vitamin D3 powder form.

Why Purchase the Report?

To visualize the global emulsified vitamin D3 market segmentation based on dosage, form, flavor, target audience, distribution channel, application and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of emulsified vitamin D3 market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global emulsified vitamin D3 market report would provide approximately 86 tables, 84 figures and 225 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1.Methodology and Scope

1.1.Research Methodology
1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

3.1.Snippet by Dosage
3.2.Snippet by Form
3.3.Snippet by Flavor
3.4.Snippet by Target Audience
3.5.Snippet by Distribution Channel
3.6.Snippet by Application
3.7.Snippet by Region

4.Dynamics

4.1.Impacting Factors
- 4.1.1.Drivers
  - 4.1.1.1.High Need to Deal with the Increasing Vitamin Deficiency Worldwide
  - 4.1.1.2.Benefits of Emulsified Vitamin D3
- 4.1.2.Restraints
  - 4.1.2.1.High-Cost of Emulsified Vitamin D3
- 4.1.3.Opportunity
- 4.1.4.Impact Analysis

5.Industry Analysis

5.1.Porter's Five Force Analysis
5.2.Supply Chain Analysis
5.3.Pricing Analysis
5.4.Regulatory Analysis
5.5.DMI Opinion

6.COVID-19 Analysis

6.1.Analysis of COVID-19
- 6.1.1.Scenario Before COVID
- 6.1.2.Scenario During COVID
- 6.1.3.Scenario Post COVID
6.2.Pricing Dynamics Amid COVID-19
6.3.Demand-Supply Spectrum
6.4.Government Initiatives Related to the Market During Pandemic
6.5.Manufacturers Strategic Initiatives
6.6.Conclusion

7.By Dosage

7.1.Introduction
- 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
- 7.1.2.Market Attractiveness Index, By Dosage
7.2.Low Dose (400 IU)
- 7.2.1.Introduction
- 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3.Volume-Based Systems
7.4.Medium Dose (1,000 IU)
7.5.High Dose (2,000 IU or more)

8.By Form

8.1.Introduction
- 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 8.1.2.Market Attractiveness Index, By Form
8.2.Softgels
- 8.2.1.Introduction
- 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3.Liquids (Drops)
8.4.Chewable Tablets

9.By Flavor

9.1.Introduction
- 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
- 9.1.2.Market Attractiveness Index, By Flavor
9.2.Raspberry
- 9.2.1.Introduction
- 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3.Lemon
9.4.Orange
9.5.Others

10.By Target Audience

10.1.Introduction
- 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Target Audience
- 10.1.2.Market Attractiveness Index, By Target Audience
10.2.Infants and Children
- 10.2.1.Introduction
- 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3.Pregnant and Lactating Women
10.4.Adults

11.By Distribution Channel

11.1.Introduction
- 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.1.2.Market Attractiveness Index, By Distribution Channel
11.2.Pharmacies and Drugstores
- 11.2.1.Introduction
- 11.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3.Non-agricultural
11.4.Specialty Stores
11.5.E-Commerce
11.6.Others

12.By Application

12.1.Introduction
- 12.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.1.2.Market Attractiveness Index, By Application
12.2.Food
- 12.2.1.Introduction
- 12.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
12.3.Feed
12.4.Healthcare

13.By Region

13.1.Introduction
- 13.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 13.1.2.Market Attractiveness Index, By Region
13.2.North America
- 13.2.1.Introduction
- 13.2.2.Key Region-Specific Dynamics
- 13.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
- 13.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 13.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
- 13.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Target Audience
- 13.2.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 13.2.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 13.2.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 13.2.9.1.U.S.
  - 13.2.9.2.Canada
  - 13.2.9.3.Mexico
13.3.Europe
- 13.3.1.Introduction
- 13.3.2.Key Region-Specific Dynamics
- 13.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
- 13.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 13.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
- 13.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Target Audience
- 13.3.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 13.3.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 13.3.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 13.3.9.1.Germany
  - 13.3.9.2.U.K.
  - 13.3.9.3.France
  - 13.3.9.4.Italy
  - 13.3.9.5.Spain
  - 13.3.9.6.Rest of Europe
13.4.South America
- 13.4.1.Introduction
- 13.4.2.Key Region-Specific Dynamics
- 13.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
- 13.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 13.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
- 13.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Target Audience
- 13.4.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 13.4.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 13.4.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 13.4.9.1.Brazil
  - 13.4.9.2.Argentina
  - 13.4.9.3.Rest of South America
13.5.Asia-Pacific
- 13.5.1.Introduction
- 13.5.2.Key Region-Specific Dynamics
- 13.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
- 13.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 13.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
- 13.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Target Audience
- 13.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 13.5.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 13.5.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 13.5.9.1.China
  - 13.5.9.2.India
  - 13.5.9.3.Japan
  - 13.5.9.4.Australia
  - 13.5.9.5.Rest of Asia-Pacific
13.6.Middle East and Africa
- 13.6.1.Introduction
- 13.6.2.Key Region-Specific Dynamics
- 13.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
- 13.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 13.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
- 13.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Target Audience
- 13.6.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 13.6.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

14.Competitive Landscape

14.1.Competitive Scenario
14.2.Market Positioning/Share Analysis
14.3.Mergers and Acquisitions Analysis

15.Company Profiles

15.1.BASF
- 15.1.1.Company Overview
- 15.1.2.Product Portfolio and Description
- 15.1.3.Financial Overview
- 15.1.4.Key Developments
15.2.Biotics Research Corporation
15.3.Adaptogen Research
15.4.Body of Harmony
15.5.bodykind Ltd.
15.6.Naka Pro
15.7.Nutri-Link
15.8.gnanaturals
15.9.Nutra Biogenesis
15.10.Designs for Health, Inc.

LIST NOT EXHAUSTIVE

16.Appendix

16.1.About Us and Services
16.2.Contact Us

02-2729-4219

+886-2-2729-4219

License/价格

FAQ

全球乳化维生素 D3 市场 - 2023-2030

Global Emulsified Vitamin D3 Market - 2023-2030

目录

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

第 5 章：产业分析

第 6 章：COVID-19 分析

第 7 章：按剂量

第 8 章：按形式

第 9 章：依口味

第 10 章：按目标受众

第 11 章：按配销通路

第 12 章：按应用

第 13 章：按地区

第14章：竞争格局

第 15 章：公司简介

第 16 章：附录